Paul McGale

Medical Statistician

Clinical Trial Service Unit

Paul is a medical statistician mainly working on case-control and cohort studies of side-effects of radiotherapy for breast cancer as well as meta-analyses of randomised trials of treatments for breast cancer. Other work has included investigations into health effects of prolonged tobacco smoking and also burden of disease caused by exposure to residential radon.

Recent publications

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Twenty five year risks of breast cancer mortality in 500,000 women
Conference paper

Taylor C. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Journal article

Henson KE. et al, (2020), Int J Cancer
Eligibility for Partial Breast Radiotherapy in England.
Journal article

Taylor CW. et al, (2019), Clin Oncol (R Coll Radiol)
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Journal article

Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)

More publications